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Quality of life over time in dialysis: The Netherlands Coopera- Studies on the outcome of dialysis over time have
tive Study on the Adequacy of Dialysis. mainly focused on mortality. These studies suggest that
Background. Information on the longitudinal quality of life younger patients, as well as those with less comorbidity(QL) of patients treated by different dialysis modalities is lack-
[1–5], a better nutritional status, and a greater smalling. Therefore, we performed a prospective cohort study on
solute removal [3, 4, 6] tend to live longer. Results onthe QL over time in hemodialysis (HD) and peritoneal dialysis
(PD) patients. which dialysis modality provides the highest survival rate
Methods. New chronic dialysis patients from 13 Dutch dial- are conflicting [7, 8].
ysis centers were consecutively included. The patients’ self- Currently, there is general consensus that in additionassessment of QL was measured with the SF-36e form at 3,
to survival, the quality of the remaining life is a highly6, 12, and 18 months after the start of dialysis treatment.
relevant patient outcome in the evaluation of treatment.Results. Out of 230 patients who completed the QL ques-
tionnaire at least once, 139 patients stayed on their initial dial- According to The World Health Organization, health is
ysis modality, 26 patients switched dialysis modality, 35 patients defined as “a state of complete physical, psychological
were transplanted, 28 patients died, and two patients had a and social well-being and not merely the absence ofrecovery of renal function. The QL of patients who died during
disease or infirmity” [9]. Consistent with this definition, athe study period was considerably worse at baseline and
comprehensive assessment of quality of life (QL) shouldworsened at a faster rate than in the other patient groups. In
patients who stayed on their initial dialysis modality, the physi- cover at least the patient’s functioning and well-being in
cal QL decreased over time, whereas the mental QL tended the physical, psychological, and social domains.
to remain stable. After an adjustment for the initial value of With a few exceptions [10–14], information from theQL and comorbidity, a consistently favorable effect of HD on
literature on QL of dialysis patients is derived from cross-physical QL over time was found compared with PD, whereas
sectional studies. These few longitudinal studies exam-mental QL values remained similar. Parameters of adequacy
of dialysis were not associated with QL over time. ined only hemodialysis (HD) patients [10, 12] or com-
Conclusion. This prospective cohort study shows that physi- pared QL before and after kidney transplantation [11,
cal QL over time in HD patients is better than in PD patients.
13, 14]. Moreover, the interpretation of these studies is
limited because of small sample sizes and no or insuffi-
1 The other members of the NECOSAD Study Group are: J. Baren- cient adjustment for case mix. Consequently, no informa-
dregt (Maastricht), M. Boekhout (Leiderdorp), H.R. Bu¨ller (Amster- tion is available on the long-term QL of patients treated
dam), F.Th. de Charro (Rotterdam), A. van Es (Hilversum), J.A.C.A.
by different dialysis modalities.van Geelen (Alkmaar), W. Geerlings W (‘s-Gravenhage), P.G.G. Ger-
lag (Veldhoven), J.P.M.C. Gorgels (Haarlem), R.M. Huisman (Haren), Against this background, the objective of our multi-
W.A.H. Koning-Mulder (Enschede), M.I. Koolen (‘s-Hertogenbosch), center study was to assess the QL of a cohort of newK.M.L. Leunissen (Maastricht), R. van Leusen (Arnhem), K.J.
chronic HD and peritoneal dialysis (PD) patients at 3,Parlevliet (Arnhem), C.H. Schro¨der (Utrecht), P. Stevens (Amsterdam),
J.G.P. Tijssen (Amsterdam), R.M. Valentijn (‘s-Gravenhage), H.H. 6, 12, and 18 months after the start of dialysis with an
Vincent (Nieuwegein), and P. Vos (Utrecht). established QL tool.
Key words: ESRD, hemodialysis, peritoneal dialysis, comorbidity, dial-
ysis adequacy, quality of life.
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renal replacement therapy in the past and who had sur- after dialysis when the patient was at dry weight. The
dietary protein intake was assessed as protein catabolicvived the first three months on dialysis were eligible for
rate [PCR; in HD: PCR (g/24 hr) 5 9.35 3 urea genera-the study. From 13 Dutch dialysis centers, we included
tion rate (mg/min) 1 0.294 3 urea distribution volumeconsecutive patients who started dialysis between Octo-
(L); in PD: PCR (g/24 hr) 5 19 3 0.2134 3 urea appear-ber 1, 1993, and April 1, 1995, after their informed con-
ance (mmol/24 hr)] [15, 16] normalized to actual bodysent was obtained. These patients were participating in
weight (nPCR). The urea distribution volume (V) wasthe Netherlands Cooperative Study on the Adequacy of
determined by the formulae of Watson et al [17]. Subse-Dialysis, phase 1 (NECOSAD-1). Dialysis treatment was
quently, anthropometric parameters and serum albuminprescribed by the individual patient’s physician.
were combined to a malnutrition index, corrected for
age, sex, height, and frame size, similar to the indexData collection
described by Harty et al [18], but without the use ofAt baseline, that is, three months after the start of
subjective global assessment. A score of 11 or higherdialysis, information was collected on demography, un-
was defined as severe malnutrition.derlying kidney disease, comorbid status, nutritional sta-
Renal function was estimated as the residual glomeru-
tus, hemoglobin, use of erythropoietin (EPO), residual
lar filtration rate (rGFR), renal Kt/Vurea, and renal creati-renal function, and dialysis adequacy. The QL was as-
nine clearance. The rGFR was defined as the mean renal
sessed at baseline and at 6, 12, and 18 months after the
clearance of urea and creatinine.
initiation of chronic dialysis treatment. The total removal of waste products (renal and dial-
The underlying kidney disease was classified according ysis) was measured as clearance estimated by total
to the codes of the European Dialysis and Transplant weekly Kt/Vurea and total weekly urea appearance in HDAssociation-European Renal Association Registry. Com- and PD patients. In PD patients, the total weekly creati-
orbidity was defined in terms of presence of conditions nine clearance and the total weekly creatinine appear-
not directly related to the uremic state, either at the start ance were calculated. HD Kt/Vurea was estimated usingof dialysis or in the medical history. Next, every patient a second-generation Daugirdas formula [19]. Peritoneal
was assigned a low, medium, or high survival risk index Kt/Vurea and creatinine clearance were calculated from abased on comorbidity and to a lesser extent advanced 24-hour dialysate collection.
age. This classification was described by Khan et al [2]. The HD patients collected all urine during an interdia-
The low-risk group in this classification comprised pa- lytic interval. Blood samples were taken before and after
tients less than 70 years old with no comorbid illness; the dialysis session preceding the interval and at the end
the medium risk group included patients between 70 and of this interval. The PD patients collected 24-hour urine
80 years of age and patients less than 80 years of age with and dialysate. A blood sample was taken immediately
one or more of the following diseases: angina, myocardial after the collection period.
infarction, cardiac failure, chronic obstructive airways The patients’ perception of their level of QL was as-
disease, pulmonary fibrosis, or liver diseases (cirrhosis, sessed with the 36-item MOS-Short Form Health Survey
chronic hepatitis), peripheral vascular and cerebrovascu- Questionnaire (SF-36e) [20]. The SF-36 is a generic
lar disease, and patients less than 70 years of age with multidimensional instrument consisting of eight multi-
diabetes mellitus. The high-risk group comprised pa- item scales representing physical functioning, social func-
tients more than 80 years of age, patients of any age tioning, role limitations caused by physical problems, and
with two or more organ dysfunctions in addition to role limitations caused by emotional problems, mental
ESRD, and patients of any age with visceral malignancy. health, vitality, bodily pain, and general health percep-
In addition, patients were classified according to the pres- tions. The scale scores were transformed to a 0 to 100
ence or absence of diabetes mellitus and cardiovascular scale, with a higher score indicating a better QL. Subse-
conditions (angina pectoris, myocardial infarction, class quently, the scale scores were standardized to the scale
III to IV congestive heart failure, or peripheral vascular scores of an age-matched general Dutch population sam-
disease). ple (N 5 775, age range 45 to 74, 66% male) [21]. Finally,
The nutritional status was assessed by the body mass the physical and mental components of the eight scales
index, percentage of lean body mass, serum albumin, were combined into a physical (PCS) and mental (MCS)
and an estimation of dietary protein intake. The percent- component summary score [22]. The PCS primarily re-
age of lean body mass was estimated by anthropometry flects the dimensions physical functioning, role limita-
from the sum of thickness of the triceps, biceps, subscap- tions caused by physical health problems, pain, and gen-
ular, and suprailiac skinfolds, by the method of Durnin eral health perceptions. The MCS reflects primarily
and Womersley (see note added in proof). Because skin mental health, role limitations caused by emotional prob-
turgor and hydration may affect subcutaneous skinfold lems, social functioning, and vitality. A linear T-score
transformation was used so that both PCS and MCS hadthicknesses, measurements in HD patients were made
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a mean of 50 and a standard deviation of 10 in the general mixed model is a generalization of the standard linear
model, the generalization being an ability to analyze datapopulation sample. The reliability and validity of the
SF-36 have been extensively supported in various demo- with several sources of variation instead of just one.
graphic and patient populations, including ESRD pa-
tients [20, 23–25]. In our population, internal consistency
RESULTScoefficients (Chronbach alphas) of the SF-36 scales
Baseline characteristics of patientsranged between 0.73 and 0.93.
Out of 250 included patients, 230 patients (121 HD
and 109 PD) completed the QL questionnaire at leastData analysis
once. Reasons for nonresponse and characteristics ofPatients were classified according to the following cat-
nonresponders have been described previously [26]. Twoegories: (a) patients who started and stayed on HD
patients whose renal function recovered were excludedthroughout follow-up, (b) patients who started and
from this analysis. From the remaining 228 patients (119stayed on PD throughout follow-up, (c) patients who
HD and 109 PD), 139 patients stayed on their initialswitched their dialysis modality one time or more, (d)
dialysis modality (84 HD and 55 PD), and 26 (5 HD andpatients who were transplanted, and (e) patients who
21 PD) patients switched dialysis modality. Thirty-fivedied. Patients who switched their dialysis modality and
(15 HD and 20 PD) patients were transplanted, and 28died later on were classified as deceased (N 5 5); patients
(15 HD and 13 PD) patients died during the 15 monthswho switched from one dialysis modality to the other
of follow-up. Reasons for a switch from PD to HD wereand later underwent transplantion were classified as
mainly peritonitis (N 5 11), catheter problems (N 5 2),transplanted (N 5 1).
other medical reasons (N 5 5), a combination of anorexiaDifferences in baseline characteristics between groups
and behavioral problems (N 5 1), low IQ (N 5 1), andwere analyzed with one-way analysis of variance in the
the patient’s own choice (N 5 1). The five HD patientscase of continuous variables and with chi-square tests
switched to PD because of shunt problems (N 5 3), anfor categorical variables.
inability to endure the HD procedure (N 5 1), and theRepeated-measures analysis of variance was used to
patient’s own choice (N 5 1).establish changes in the QL over time (time effect), dif-
Baseline characteristics of these patients are presentedferences in the QL between treatment groups (treatment
in Table 1, which shows that the transplanted patientseffect), and the interaction between changes in the QL
were younger and less ill, whereas the deceased pa-by time and treatment group (time by treatment effect).
tients were older and most severely ill. Significant differ-To take possible QL differences into account that may
ences were found between the five groups with respecthave selected for the choice of dialysis modality, the
to age, Khan’s comorbidity age index, cardiovascularbaseline QL was included as a covariate. In addition,
comorbidity, diabetes mellitus, body mass index, albu-the results were adjusted for the possible confounding
min, hemoglobin, use of EPO, and the renal creatinineeffects of age, gender, clinical characteristics, nutritional
appearance rate (all P , 0.05).status, and adequacy of dialysis. All factors that were
The baseline physical and mental QL of all patientunivariately associated with a P value # 0.20 were taken
groups was significantly lower than the correspondinginto account as covariates in the analysis of variance. As
values of an age-matched general population sample.parameters of dialysis dose are not equally calculated
The QL of stay-on-PD and transplanted patients wasfor HD and PD patients, these variables were analyzed
more or less similar, followed by, in rank order of de-separately for HD and PD patients. Based on these mod-
creasing QL, stay-on-HD, dialysis switchers, and de-els, mean effects with their 95% confidence intervals
ceased patients. Only the differences in the physical QL(95% CI) were calculated.
between stay-on-PD and transplanted patients on theTo study the influence of selective dropout, the re-
one side and deceased patients on the other side werepeated-measures analysis of variance was repeated on
significant (P 5 0.001).an intention-to-treat basis, that is, according to the initial
dialysis modality irrespective of modality switches, trans-
Quality of life over timeplantation, and death during follow-up.
The descriptive analyses were carried out using SPSS In Figure 1, the physical and mental QL during follow-
up is displayed for all patients according to their stay onfor Windows 8.0 software (SPSS Inc., Chicago, IL, USA).
The repeated-measures analysis of variance was per- mode of renal replacement therapy. Because follow-up
was discontinued after transplantation, no QL assess-formed with the mixed procedure of SAS for Windows
6.12 statistical software (SAS Institute Inc., Cary, NC, ment can be given at 18 months in the subgroup of
patients who were transplanted during the study period.USA). The mixed procedure fits mixed linear models,
that is, models with both fixed and random effects. A The physical QL of patients who died during the study
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Table 1. Baseline characteristics [mean (sd) or %]
Stay on HD Stay on PD Dialysis switchersa Transplantedb Deceasedc
(N 5 84) (N 5 55) (N 5 26) (N 5 35) (N 5 28)
Agee 60 (15) 52 (14) 51 (14) 45 (13) 67 (10)
Male 55% 69% 58% 57% 64%
Primary kidney disease
Diabetes mellitus 12% 18% 8% 3% 29%
Glomerulonephritis 12% 16% 12% 23% 4%
Vascular 27% 24% 19% 20% 29%
Other 49% 42% 62% 54% 39%
Medium and high comorbidity-age index
(Khan index)e 60% 42% 65% 11% 82%
Cardiovascular comorbiditye 33% 22% 35% 6% 43%
Diabetes mellituse 17% 22% 8% 6% 32%
Percentage lean body mass 73.2 (9.1) 77.0 (7.7) 78.0 (9.3) 76.3 (6.9) 73.0 (7.8)
Body mass index (kg/m2)e 24.7 (4.7) 23.3 (3.3) 22.2 (3.9) 22.6 (2.9) 24.6 (4.1)
Severe malnutrition (Harty index) 12% 16% 31% 9% 11%
Protein catabolic rate g/kg/dayd 1.0 (0.3) 1.3 (0.3) — — —
Albumine g/liter 39.5 (4.2) 37.5 (5.7) 35.7 (6.3) 37.2 (4.5) 35.1 (5.4)
Hemoglobine g/dl 10.2 (1.2) 11.4 (1.5) 10.4 (1.8) 10.6 (1.2) 10.1 (1.5)
Use of erythropoietine 87% 64% 73% 66% 79%
Residual GFR ml/min/1.73 m2 2.8 (2.1) 3.1 (2.3) 2.8 (2.3) 4.0 (3.0) 3.0 (2.2)
Kt/Vurea /week
Totald 3.4 (1.0) 2.1 (0.5) — — —
Renal 0.5 (0.4) 0.6 (0.5) 0.5 (0.4) 0.8 (0.6) 0.6 (0.5)
Creatinine clearance liter/week/1.73 m2
Totald — 84 (30) — — —
Renal 36 (30) 41 (32) 35 (31) 53 (39) 37 (30)
Urea appearance mmol/week/1.73 m2
Totald 2140 (628) 1770 (545) — — —
Renal 377 (320) 478 (408) 411 (385) 580 (406) 399 (303)
Creatinine appearance mmol/week/1.73 m2
Totald — 67.9 (16.8) — — —
Renale 20.8 (14.1) 30.6 (19.9) 25.6 (23.7) 36.2 (22.3) 21.3 (13.8)
Physical summary QL score 40.7 (8.8) 43.6 (7.3) 41.0 (9.3) 44.2 (8.2) 36.4 (9.7)
Mental summary QL score 44.9 (11.9) 46.1 (7.5) 40.4 (12.5) 46.4 (10.5) 40.1 (11.8)
a,b,c Initial dialysis mode: a 5 HD, 21 PD; b 15 HD, 20 PD; c 15 HD, 13 PD; all modality changes, transplantations and deaths took place within the study period
d Mean values cannot be calculated in dialysis switchers, transplanted and deceased patients due to the mixed composition of these groups with respect to dialysis
mode
e Significant differences between groups (P , 0.05)
period was considerably worse at baseline and worsened Statistical analysis of the QL over time was restricted
to the stay-on-HD and PD because of the small numberat a faster rate before dying than in the other patient
groups. Transplanted patients started off at the same of patients and the high dropout rate in the other catego-
ries.level as stay-on-PD patients but improved with time,
whereas the stay-on-PD patients worsened with time.
Physical quality of life over time: Stay-on-hemodialysisThe physical QL of patients who changed their initial
versus stay-on-peritoneal dialysis patientsdialysis modality was similar to the QL of stay-on-HD
patients during the first year of dialysis treatment but Overall, a statistically significant decline in the physical
QL over time was observed (18 vs. 3 months, 21.9 points;decreased faster afterward (Fig. 1).
The initial value of the mental QL in the patients who 95% CI, 23.3 to 20.5, P 5 0.02; Fig. 1). This decline
tended to be more pronounced in PD compared with HDdied before the end of the study period was consider-
ably lower than the stay-on-dialysis and transplanted patients (time–treatment interaction effect, P 5 0.06).
When a correction was applied for differences in thepatients, and deteriorated rapidly with time. Patients
who switched from dialysis modality also reported a baseline physical QL, a significant treatment effect was
found: Patients on HD did better compared with PD,lower mental QL at baseline but showed an inconsistent
pattern of change during follow-up. The mental QL over with a mean difference over time of 2.3 points (95% CI,
0.3 to 4.3, P 5 0.03). This adjustment for the baselinetime of patients who were transplanted during the study
period was similar to the stay-on-PD patients. Mental QL QL value did not change the time effect, whereas the
borderline significant time–treatment interaction effectscores of both stay-on-dialysis and transplanted patients
were closer to the general population norm than their disappeared. These effects remained stable after an addi-
tional correction for other baseline characteristics thatphysical QL scores.
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Fig. 1. Change over time in physical and mental summary quality of
life (QL) according to the stay on mode of renal replacement therapy
(means 6 SE). QL values are normalized to a general population mean
of 50 and a standard deviation of 10 (that is, a T-score metric, as
Fig. 2. Change over time in physical and mental summary quality ofdiscussed in the Methods section). Symbols are: (j) stay on PD; (d)
life (QL) of the stay on HD (d) and the stay on PD (j) patientsstay on HD; (,) dialysis switchers; (s) transplanted; (e) deceased.
adjusted for the baseline value of QL and comorbid status (means 6
SE). QL values are normalized to a general population mean of 50 and
a standard deviation of 10 (that is, a T-score metric, as discussed in the
Methods section).
were univariately related (P # 0.20) to the physical QL
over time (age, comorbidity-age index, diabetes mellitus,
hemoglobin, and albumin; Fig. 2). Only the comorbidity- individual subdimensions (further details of the individ-
ual SF-36 scales over time are shown in Table 2).age index contributed significantly to this model: Patients
with a medium or high comorbidity-age index were con-
Mental quality of life over time: Stay-on-hemodialysissistently more impaired compared with patients with a
versus stay-on-peritoneal dialysis patientslow comorbidity-age index (mean difference over time,
22.7 points; 95% CI, 24.7 to 20.6, P 5 0.01). No overall significant decline in the mental QL over
time could be demonstrated, although there appearedAn analysis of the four individual scales that compose
the physical QL summary score indicated that the time to be a slight decline in PD toward the end of follow-
up (Fig. 1). There was no significant difference in theeffect was concentrated in the physical functioning scale
(18 vs. 6 months, 26.7 points, 95% CI, 210.2 to 23.2, mental QL between HD and PD, and this result did not
change after a correction for the baseline mental QL.P 5 0.001) and somewhat less in the general health
perceptions scale (18 vs. 6 months, 24.9 points, 95% CI, An additional correction for other baseline characteris-
tics that were univariately related (P # 0.20) to mental28.2 to 20.5, P 5 0.02), whereas the treatment effect
was concentrated in the body pain dimension (PD vs. QL over time (comorbidity age index, cardiovascular
comorbidity, residual GFR, renal urea appearance, renalHD, 27.8 points, 95% CI, 214.9 to 20.7, P 5 0.03). No
time–treatment interaction effects were observed for the creatinine appearance, and the renal Kt/Vurea) did not
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Table 2. Adjusted meansa (standard error) of the individual SF-36E scales over time by dialysis modality
Stay on HD months Stay on PD months
SF-36E scale 6 12 18 6 12 18
Physical QL
Physical functioningb 59.4 (1.9) 55.5 (2.0) 53.4 (2.1) 56.4 (2.4) 53.9 (2.4) 48.8 (2.5)
Role functioning, physical 38.4 (4.3) 38.3 (4.5) 39.1 (4.5) 27.8 (5.2) 34.4 (5.3) 29.4 (5.4)
Bodily painc 71.9 (2.8) 71.4 (2.9) 69.9 (3.0) 65.7 (3.4) 64.4 (3.5) 59.3 (3.6)
General health perceptionsb 45.8 (1.8) 44.4 (1.9) 43.7 (1.9) 47.8 (2.2) 45.7 (2.2) 38.9 (2.3)
Mental QL
Mental health 69.5 (1.8) 68.9 (1.9) 68.2 (1.9) 69.5 (2.3) 69.1 (2.3) 65.5 (2.3)
Role functioning-emotional 57.4 (4.7) 57.2 (4.9) 57.0 (5.0) 62.3 (5.8) 62.4 (5.9) 57.0 (6.0)
Social functioningb 71.5 (2.6) 67.5 (2.6) 67.9 (2.7) 68.9 (3.1) 68.1 (3.2) 61.3 (3.3)
Vitalityb 51.8 (1.9) 50.5 (2.0) 48.5 (2.0) 50.3 (2.3) 47.7 (2.4) 44.5 (2.4)
Abbreviations are: QL, quality of life; HD, hemodialysis; PD, peritoneal dialysis.
a Adjusted for baseline QL and comorbidity (Kahn’s risk index in case of the physical QL scales and cardiovascular comorbidity in case of the mental QL scales
b Significant time effect (P , 0.05)
c Significant treatment effect (P , 0.05)
change these results either (Fig. 2). Only cardiovascular diovascular comorbidity, this treatment effect disap-
peared (Fig. 3).comorbidity contributed significantly to this model. Pa-
tients with cardiovascular comorbidity had a lower men-
tal QL (mean difference over time 23.0 points; 95% CI, DISCUSSION
25.7 to 20.3, P 5 0.03).
This study explored the relationship between dialysisAlthough no time effect was observed in the mental
modality and the physical and mental QL during the firstQL summary score, an inspection of the composing
18 months of renal replacement therapy. In line withscales revealed a significant time effect in the social func-
findings in other dialysis patients [6, 27], the mental QLtioning and vitality scale. Both QL subdimensions
appeared closer to normal than the physical QL. In pa-showed a deterioration with time (social functioning 18
tients who stayed on their initial dialysis modality, thevs. 6 months, 25.2 points, 95% CI, 29.3 to 21.1, P 5
physical QL decreased over time, whereas the mental
0.047; vitality 24.3 points, 95% CI, 27.5 to 21.2, P 5
QL tended to remain stable. After adjustment for the
0.03; Table 2). Neither a treatment nor a treatment–time initial value of QL, there appeared to be a consistently
interaction effect was observed in any of the mental favorable effect of HD on the physical QL over time
subdimensions (further details of the individual SF-36 compared with PD, whereas the mental QL remained
scales over time are shown in Table 2). similar. A correction for other significant baseline char-
acteristics did not change the observed time and treat-Intention-to-treat analysis
ment effects. It implies that a HD patient will rate his/her
Additionally, we assessed the change over time in physical QL more favorably during the first 18 months of
physical and mental summary QL with an intention-to- dialysis compared with a PD patient who has a similar
treat approach. Regarding the physical QL, a significant clinical status and physical QL at the start of dialysis
decline in course of time was observed (18 vs. 3 months, treatment.
22.0, 95% CI, 23.2 to 20.8, P , 0.01). No statistically As we were especially interested in the midterm effects
significant treatment effect nor a different change pattern of HD and PD on QL, we initially studied only those
over time was observed between HD and PD patients. patients who stayed on their initial dialysis modality
After adjustment for baseline differences in physical QL throughout the study period. This may have slightly bi-
and comorbid status (comorbidity age index), the physi- ased the estimated effects, as only therapy survivors were
cal QL of HD patients was still favorable to that of PD analyzed. However, when we repeated the analysis for
patients (HD vs. PD, 1.6; 95% CI, 0.04 to 3.2, P 5 0.04), any patient who started chronic HD or PD irrespective of
whereas the time effect remained unchanged (18 vs. 6 stay on that modality (that is, intention-to-treat analysis)
months, 22.0; 95% CI, 23.2 to 20.8, P , 0.01; Fig. 3). virtually similar time, treatment and treatment–time in-
No change over time in the mental summary QL was teraction effects were observed for both the physical and
observed for both treatment groups. HD patients re- mental QL.
ported a consistently lower mental QL at all time points An analysis of the scales that primarily compose the
compared with PD patients (HD vs. PD 22.6; 95% CI, physical summary QL score indicated that the time effect
25.0 to 20.2, P 5 0.03). However, after correction for was concentrated in the physical functioning (limitations
in physical activities) and somewhat less in the generalbaseline differences in the mental summary QL and car-
Merkus et al: Quality of life over time in dialysis726
This discrepancy between individual subscale scores and
the calculated summary score might be a consequence
of the assumptions and methods used to calculate these
summary scores [28]. Thus, although the use of summary
scores has the advantage to reduce the number of statisti-
cal comparisons and thereby the role of chance in testing
hypotheses, relevant subscale-time or subscale-treat-
ment interactions may be missed. Therefore, we suggest
that it is useful not only to focus on the summary QL
but also to inspect individual subscales, keeping in mind
the statistical problem of multiple comparisons [29, 30].
What is the clinical meaning of the observed differ-
ences in QL in this study? A comparison of these results
with differences in QL observed in other (dialysis) popu-
lations or comparison with differences seen with therapy
of proven benefit, such as EPO, may help with an inter-
pretation. For example, the difference of 2.3 points in
the physical summary QL between our HD and PD pa-
tients is approximately half of the difference in the physi-
cal summary QL observed between cancer patients and
the general population of the United States [22]. The
difference of 7.8 points in bodily pain between our HD
and PD patients is similar to the difference in bodily
pain observed in type II diabetes patients compared with
general population norms [20]. The deterioration in
physical functioning of 6.7 points in our population is
approximately twice the magnitude of change in physical
functioning observed in a before-and-after EPO study
among HD patients [27]. In the latter study, a change
of approximately nine points in vitality and eight points
in social functioning was seen, compared with a decre-
ment of approximately four points in vitality and five
Fig. 3. Change over time in the physical and mental summary quality points in social functioning in our population during fol-
of life (QL) according to the initial dialysis modality (that is, intention- low-up.to-treat analysis) adjusted for the baseline value of QL and comorbid
In our study, we also examined the effect of baselinestatus (means 6 SE). QL values are normalized to a general population
mean of 50 and a standard deviation of 10 (that is, a T-score metric, patient characteristics and adequacy of dialysis on the
as discussed in the Methods section). Symbols are: (d) intention to QL over time. Comorbidity was the only variable associ-treat HD; (j) intention to treat PD.
ated with QL over time. A higher comorbidity age index
according to Khan et al correlated with a more impaired
physical QL over time [2]. Recently, it has been demon-
strated that this index provided the greatest discrimina-health perceptions dimension (personal evaluations of
health), whereas the treatment effect was concentrated tion between patient groups at risk for mortality when
compared with an index that combined the effect ofin the bodily pain dimension (intensity of pain and effect
of pain on normal activities). The permanent physical age and diabetes or an index based on the number of
comorbid conditions [1]. Our study shows that this Khanburden of PD compared with the intermittent character
of HD and peritonitis may be alternate explanations for comorbidity age index is also valuable to identify patients
at risk for a poor physical QL over time. The mentalthe higher pain perception of PD patients. A potential
superiority of HD regarding dialysis adequacy was not QL was associated with the presence of cardiovascular
comorbidity but not with the Khan index.supported by these adequacy parameters studied: In both
HD and in PD, none of the estimates of the adequacy None of these parameters of adequacy of dialysis were
associated with QL over time. This supports the absenceof dialysis was associated with the physical QL.
No change over time was observed for the mental of an association of adequacy of dialysis with QL that
we observed in our previous report [26]. Also, DeOreosummary QL. An inspection of the individual subscales
that predominantly reflect mental QL showed a signifi- did not find an association between Kt/Vurea and physical
QL in a sample of approximately 1000 prevalent patients,cant decline with time for social functioning and vitality.
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